GR3024989T3 - Process for preparing crystalline loracarbef monohydrate. - Google Patents

Process for preparing crystalline loracarbef monohydrate.

Info

Publication number
GR3024989T3
GR3024989T3 GR970402632T GR970402632T GR3024989T3 GR 3024989 T3 GR3024989 T3 GR 3024989T3 GR 970402632 T GR970402632 T GR 970402632T GR 970402632 T GR970402632 T GR 970402632T GR 3024989 T3 GR3024989 T3 GR 3024989T3
Authority
GR
Greece
Prior art keywords
preparing crystalline
loracarbef monohydrate
crystalline loracarbef
monohydrate
crystalline monohydrate
Prior art date
Application number
GR970402632T
Other languages
English (en)
Inventor
Robert Louis Nist
Marvin Emanuel Wildfeuer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3024989T3 publication Critical patent/GR3024989T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
GR970402632T 1993-06-04 1997-10-09 Process for preparing crystalline loracarbef monohydrate. GR3024989T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/071,552 US5352782A (en) 1993-06-04 1993-06-04 Process for preparing crystalline β-lactam monohydrate

Publications (1)

Publication Number Publication Date
GR3024989T3 true GR3024989T3 (en) 1998-01-30

Family

ID=22102062

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402632T GR3024989T3 (en) 1993-06-04 1997-10-09 Process for preparing crystalline loracarbef monohydrate.

Country Status (29)

Country Link
US (1) US5352782A (el)
EP (1) EP0627431B1 (el)
JP (1) JPH06345761A (el)
KR (1) KR950000702A (el)
CN (1) CN1045296C (el)
AT (1) ATE156129T1 (el)
AU (1) AU682503B2 (el)
BR (1) BR9402150A (el)
CA (1) CA2125000A1 (el)
CO (1) CO4230099A1 (el)
CZ (1) CZ284225B6 (el)
DE (1) DE69404560T2 (el)
DK (1) DK0627431T3 (el)
ES (1) ES2105524T3 (el)
FI (1) FI942632A (el)
GR (1) GR3024989T3 (el)
HU (1) HU217067B (el)
IL (1) IL109870A (el)
MY (1) MY110725A (el)
NO (1) NO307052B1 (el)
NZ (1) NZ260652A (el)
PE (1) PE13295A1 (el)
PH (1) PH30184A (el)
PL (1) PL174535B1 (el)
RU (1) RU2130456C1 (el)
TW (1) TW449596B (el)
UA (1) UA34440C2 (el)
YU (1) YU33494A (el)
ZA (1) ZA943826B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
CA2506872A1 (en) * 2002-11-21 2004-06-03 Ranbaxy Laboratories Limited Monohydrate solvates of loracarbef

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
US3502663A (en) * 1969-04-21 1970-03-24 Lilly Co Eli Crystalline cephalosporin,method for its manufacture
CA1334970C (en) * 1987-10-06 1995-03-28 Carol Elaine Pasini Crystalline .beta.-lactam hydrate
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor

Also Published As

Publication number Publication date
NZ260652A (en) 1995-09-26
HU217067B (hu) 1999-11-29
JPH06345761A (ja) 1994-12-20
CN1045296C (zh) 1999-09-29
PH30184A (en) 1997-01-21
IL109870A0 (en) 1994-10-07
DE69404560D1 (de) 1997-09-04
ZA943826B (en) 1995-12-01
CA2125000A1 (en) 1994-12-05
NO942049D0 (no) 1994-06-02
AU682503B2 (en) 1997-10-09
CO4230099A1 (es) 1995-10-19
IL109870A (en) 1998-06-15
ATE156129T1 (de) 1997-08-15
ES2105524T3 (es) 1997-10-16
DE69404560T2 (de) 1997-12-18
HUT67975A (en) 1995-05-29
RU94019423A (ru) 1996-04-20
PL303677A1 (en) 1995-01-09
NO942049L (no) 1994-12-05
FI942632A0 (fi) 1994-06-03
CN1097755A (zh) 1995-01-25
RU2130456C1 (ru) 1999-05-20
MY110725A (en) 1999-01-30
PE13295A1 (es) 1995-05-24
CZ134194A3 (en) 1994-12-15
DK0627431T3 (da) 1997-08-25
KR950000702A (ko) 1995-01-03
YU33494A (sh) 1996-10-18
US5352782A (en) 1994-10-04
UA34440C2 (uk) 2001-03-15
CZ284225B6 (cs) 1998-09-16
HU9401674D0 (en) 1994-09-28
EP0627431B1 (en) 1997-07-30
TW449596B (en) 2001-08-11
AU6451794A (en) 1994-12-08
FI942632A (fi) 1994-12-05
PL174535B1 (pl) 1998-08-31
NO307052B1 (no) 2000-01-31
BR9402150A (pt) 1994-12-27
EP0627431A1 (en) 1994-12-07

Similar Documents

Publication Publication Date Title
HUT35666A (en) Process for producing 6-fluoro-1,4-dihydro-4-oxo-7-substituted-piperazinyl-quinoline-3-carboxylic acid derivatives
HUT38613A (en) Process for producing substituted 1-amino-cyclobutene-3,5-dion derivatives
ZA979229B (en) Process for producing L-amino acid through fermentation.
HUT62011A (en) Process for producing factors influencing the functioning of stem cells
HK1043710A1 (en) Process for the preparation of (n-phenylacetyl-n-2,6-xylil)methyl alaninate
EP0410792A3 (en) Double bubble process for making strong, thin films
GR3024989T3 (en) Process for preparing crystalline loracarbef monohydrate.
EP0464582A3 (en) Process for the purification of riboflavin obtained by fermentation
ZA957278B (en) Stereoselective process for producing dihydro-2,3-benzo-diazepine derivatives
HUT55399A (en) Process for producing substituted 3-piperazinyl-1-deoxy-15-deoxo-1,15-epoxyrifamycin derivatives
HUT49124A (en) Process for producing 1-propargyl-2,4-dioxo-imidazolidine
HUT46327A (en) Process for producing 3-(alkanoyl-oxy-methyl)-3-cefem-4-carboxylic acid derivatives
FR2633449B1 (fr) Procede de remise en forme de pieces localement deteriorees, notamment anticathodes
HUT46883A (en) Process for producing stable, crystalline sodium acetylsalicylate
HUT34503A (en) Process for producing of 7-/2-/2-amino-4-tiazolil-imino-acetamidol/-2-carboxi-3-/2-/5,6-dioxo-4-formil-metil-1,4,5,6-tetrahidro-1,2,4-triazin-3-il/-tio-vinil/-8-oxo-5-tia-1-aza-bicyclo/4.2.0/okt-2-en sin.izomeric acid-additional,e-formed crictallic salts
EP0248238A3 (en) Process for the preparation by fermentation of l-isoleucine from d,l-alpha-hydroxybutyrate
AU3566795A (en) Process for preparing d,l-aspartic acid from ammonium salts of the maleic acid
EP0845460A4 (en) PROCESS FOR PRODUCING 4a-ARYLDECAHYDROISOQUINOLINE DERIVATIVES
HU908452D0 (en) Process for the production of 1-threonine by fermentation
YU43381B (en) Process for making pharmaceutically useful 2-methyl-4-hydroxy-2h-1,2-benzothiazine-1,1-dioxide-3-(n-2-pyridil)-carboxamide
HU208436B (en) Process for producing 1-hydroxy-ethan-1,1-diphosphonic acid
IL79890A0 (en) Plant for evaporation of water,by neutralizing the hydrogen bonds between the water molecules
GR3033709T3 (en) Process for the preparation of L-tertiairy-leucin by transamination.
HRP921218B1 (en) Process for the preparation of 4-demethoxydaunomycinone, the aglycone of 4-demethoxy-daunorubicin
HUT59108A (en) Process for producing new, 5-benzyl-substituted benzimidazoline-2-thione derivatives